Published in Lancet on March 26, 1983
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev (1998) 8.74
Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol (1987) 6.13
Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun (1985) 5.04
Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun (1991) 4.63
H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol (1985) 3.91
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76
Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc Natl Acad Sci U S A (1987) 3.25
Colonization of chicken cecae by Escherichia coli associated with hemorrhagic colitis. Appl Environ Microbiol (1985) 3.18
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun (1990) 3.02
Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun (1990) 3.00
Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidemiol Infect (1987) 2.98
Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun (1999) 2.92
A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol (2000) 2.72
Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol (1985) 2.70
Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J Bacteriol (1987) 2.65
Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I. Proc Natl Acad Sci U S A (1988) 2.38
Transduction of enteric Escherichia coli isolates with a derivative of Shiga toxin 2-encoding bacteriophage phi3538 isolated from Escherichia coli O157:H7. Appl Environ Microbiol (1999) 2.37
Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J Clin Microbiol (2000) 2.18
Shiga toxin-producing Escherichia coli strains from bovines: association of adhesion with carriage of eae and other genes. J Clin Microbiol (1996) 2.07
Structural analysis of phage-borne stx genes and their flanking sequences in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1 strains. Infect Immun (2000) 2.01
Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1. Infect Immun (1988) 1.94
Shiga-like cytotoxin production by enteropathogenic Escherichia coli serogroups. Infect Immun (1985) 1.87
A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun (1999) 1.86
Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol (2008) 1.82
Rectoanal mucosal swab culture is more sensitive than fecal culture and distinguishes Escherichia coli O157:H7-colonized cattle and those transiently shedding the same organism. J Clin Microbiol (2003) 1.78
Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples. J Clin Microbiol (2004) 1.71
Causes of the haemolytic uraemic syndrome. BMJ (1989) 1.66
Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol (1999) 1.65
Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans. J Clin Microbiol (2002) 1.58
Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol (1993) 1.58
Prevalence of verocytotoxigenic Escherichia coli in ground beef, pork, and chicken in southwestern Ontario. Epidemiol Infect (1990) 1.57
Temperature- and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli. Infect Immun (1996) 1.55
Transcriptional regulation of the esp genes of enterohemorrhagic Escherichia coli. J Bacteriol (1999) 1.53
The EspD protein of enterohemorrhagic Escherichia coli is required for the formation of bacterial surface appendages and is incorporated in the cytoplasmic membranes of target cells. Infect Immun (1999) 1.45
Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J Clin Microbiol (2004) 1.37
Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine. Infect Immun (1996) 1.37
Characterization of SepL of enterohemorrhagic Escherichia coli. J Bacteriol (2000) 1.23
Haemorrhagic colitis: detection of verotoxin producing Escherichia coli O157 in a clinical microbiology laboratory. J Clin Pathol (1988) 1.21
Bacterial toxins: friends or foes? Emerg Infect Dis (1999) 1.18
Pas, a novel protein required for protein secretion and attaching and effacing activities of enterohemorrhagic Escherichia coli. J Bacteriol (1998) 1.17
Cattle can be a reservoir of sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H(-) strains and a source of human diseases. J Clin Microbiol (2000) 1.16
Escherichia coli diarrhoea. J Hyg (Lond) (1985) 1.16
Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol (2013) 1.14
Differences in growth of Salmonella enterica and Escherichia coli O157:H7 on alfalfa sprouts. Appl Environ Microbiol (2002) 1.14
The SXT conjugative element and linear prophage N15 encode toxin-antitoxin-stabilizing systems homologous to the tad-ata module of the Paracoccus aminophilus plasmid pAMI2. J Bacteriol (2006) 1.11
Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) (2012) 1.10
Differences in attachment of Salmonella enterica serovars and Escherichia coli O157:H7 to alfalfa sprouts. Appl Environ Microbiol (2002) 1.07
A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit. Infect Immun (1990) 1.05
Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb Pathog (2010) 1.02
Effects of Long Term Antibiotic Therapy on Human Oral and Fecal Viromes. PLoS One (2015) 1.02
An outbreak of Escherichia coli O157:H7 infection in southern Sweden associated with consumption of fermented sausage; aspects of sausage production that increase the risk of contamination. Epidemiol Infect (2007) 1.01
A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli. Toxins (Basel) (2012) 1.00
Scanning and transmission electron microscopic study of adherence of Escherichia coli O103 enteropathogenic and/or enterohemorrhagic strain GV in enteric infection in rabbits. Infect Immun (1991) 1.00
Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains. Clin Exp Immunol (2008) 0.99
Shiga Toxin (Stx) Classification, Structure, and Function. Microbiol Spectr (2014) 0.99
HeLa cell adherence and cytotoxin production by enteropathogenic Escherichia coli isolated from infants with diarrhea in Thailand. J Clin Microbiol (1987) 0.98
Ribosome-inactivating proteins: potent poisons and molecular tools. Virulence (2013) 0.94
A longitudinal study of Vero cytotoxin producing Escherichia coli in cattle calves in Sri Lanka. Epidemiol Infect (1993) 0.94
Detection of Escherichia coli O157:H7 in the beef marketed in Malaysia. Appl Environ Microbiol (1998) 0.93
Diarrheagenic Escherichia coli in children from Costa Rica. Am J Trop Med Hyg (2010) 0.92
NsrR, GadE, and GadX interplay in repressing expression of the Escherichia coli O157:H7 LEE pathogenicity island in response to nitric oxide. PLoS Pathog (2014) 0.92
Sensitive detection of Shiga Toxin 2 and some of its variants in environmental samples by a novel immuno-PCR assay. Appl Environ Microbiol (2011) 0.90
Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol (2012) 0.90
Culture confirmation of Escherichia coli serotype O157:H7 by direct immunofluorescence. J Clin Microbiol (1990) 0.88
Detection and characterization of the fimbrial sfp cluster in enterohemorrhagic Escherichia coli O165:H25/NM isolates from humans and cattle. Appl Environ Microbiol (2008) 0.87
High-throughput method for rapid induction of prophages from lysogens and its application in the study of Shiga Toxin-encoding Escherichia coli strains. Appl Environ Microbiol (2010) 0.87
Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol (2014) 0.87
Nucleotide sequence of the integration site of the temperate bacteriophage 6220, which carries the Shiga toxin gene stx(1ox3). J Bacteriol (2003) 0.84
Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli. Biochem J (2012) 0.83
Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract. Virulence (2013) 0.83
Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits. Comp Med (2010) 0.82
Mapping the minimal contiguous gene segment that encodes functionally active Shiga-like toxin II. Infect Immun (1991) 0.82
Hemolytic-uremic syndrome associated with verotoxin-producing Escherichia coli. Can Med Assoc J (1985) 0.82
Overview and Historical Perspectives. Microbiol Spectr (2014) 0.81
Shiga toxin 2a and Enteroaggregative Escherichia coli--a deadly combination. Gut Microbes (2015) 0.81
Vibrio parahaemolyticus, enterotoxigenic Escherichia coli, enterohemorrhagic Escherichia coli and Vibrio cholerae. Proc Jpn Acad Ser B Phys Biol Sci (2011) 0.80
The EHEC-host interactome reveals novel targets for the translocated intimin receptor. Sci Rep (2014) 0.80
Evaluation of CHROMagar STEC and STEC O104 chromogenic agar media for detection of Shiga Toxin-producing Escherichia coli in stool specimens. J Clin Microbiol (2013) 0.79
Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications. Toxins (Basel) (2016) 0.78
Shiga toxin 1 causes direct renal injury in rats. Infect Immun (2005) 0.78
Fates of acid-resistant and non-acid-resistant Shiga toxin-producing Escherichia coli strains in ruminant digestive contents in the absence and presence of probiotics. Appl Environ Microbiol (2009) 0.77
Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Front Med (Lausanne) (2014) 0.77
Escherichia coli O157:H7 Strain EDL933 Harbors Multiple Functional Prophage-Associated Genes Necessary for the Utilization of 5-N-Acetyl-9-O-Acetyl Neuraminic Acid as a Growth Substrate. Appl Environ Microbiol (2016) 0.76
Fiber-Optic Fluoroimmunoassay System with a Flow-Through Cell for Rapid On-Site Determination of Escherichia coli O157:H7 by Monitoring Fluorescence Dynamics. Biosensors (Basel) (2013) 0.75
A New Immunoassay for Detecting All Subtypes of Shiga Toxins Produced by Shiga Toxin-Producing E. coli in Ground Beef. PLoS One (2016) 0.75
Experimental Infection of Calves with Escherichia coli O104:H4 outbreak strain. Sci Rep (2016) 0.75
Longitudinal Study of Two Irish Dairy Herds: Low Numbers of Shiga Toxin-Producing Escherichia coli O157 and O26 Super-Shedders Identified. Front Microbiol (2016) 0.75
Verocytotoxin producing Escherichia coli. BMJ (1991) 0.75
Genetic makeup of Shiga toxin-producing Escherichia coli in relation to clinical symptoms and duration of shedding: a microarray analysis of isolates from Swedish children. Eur J Clin Microbiol Infect Dis (2017) 0.75
EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY. J Bacteriol (1964) 19.60
Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun (1982) 13.55
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05
Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science (1984) 7.94
Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect Immun (1983) 6.43
Shigella sonnei plasmids: evidence that a large plasmid is necessary for virulence. Infect Immun (1981) 6.40
Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans. Infect Immun (1972) 6.21
Protein synthesis in HeLa or Henle 407 cells infected with Shigella dysenteriae 1, Shigella flexneri 2a, or Salmonella typhimurium W118. Infect Immun (1981) 5.39
Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen. Infect Immun (1980) 4.87
Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli. Infect Immun (1983) 4.82
Shigellosis due to Shigella dysenteriae. 1. Relative importance of mucosal invasion versus toxin production in pathogenesis. J Infect Dis (1972) 4.60
Experimental bacillary dysentery. An electron microscopic study of the response of the intestinal mucosa to bacterial invasion. Am J Pathol (1965) 4.42
Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J Infect Dis (1973) 4.22
Plaque formation by virulent Shigella flexneri. Infect Immun (1985) 4.16
Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp. Infect Immun (1986) 3.87
Identification and antigenic characterization of virulence-associated, plasmid-coded proteins of Shigella spp. and enteroinvasive Escherichia coli. Infect Immun (1985) 3.78
Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis (1989) 3.71
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens. Infect Immun (1972) 3.33
Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol (1980) 3.31
Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin. Biochem Biophys Res Commun (1976) 3.30
Intracellular spread of Shigella flexneri associated with the kcpA locus and a 140-kilodalton protein. Infect Immun (1989) 3.24
Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. Lancet (1984) 3.05
Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun (1977) 2.94
Molecular characterization of plasmids from virulent and spontaneously occurring avirulent colonial variants of Shigella flexneri. Infect Immun (1979) 2.93
Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J Clin Invest (1973) 2.78
Experimental clindamycin-associated colitis in rabbits. Evidence of toxin-mediated mucosal damage. Gastroenterology (1978) 2.63
Fluorescent-antibody and histological study of vaccinated and control monkeys challenged with Shigella flexneri. J Bacteriol (1966) 2.60
Exerimental acute colitis in the Rhesus monkey following peroral infection with Shigella flexneri. An electron microscope study. Am J Pathol (1968) 2.53
Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin. Infect Immun (1980) 2.47
Plasmid-mediated invasiveness of "Shigella-like" Escherichia coli. Ann Microbiol (Paris) (1982) 2.38
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol (1966) 2.23
Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. Infect Immun (1982) 2.21
Invasive Escherichia coli. J Infect Dis (1978) 2.19
Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun (1981) 2.15
Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun (1988) 2.12
Inhibition of protein synthesis by Shiga toxin: activation of the toxin and inhibition of peptide elongation. FEBS Lett (1980) 2.05
The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97
Invasive enteric pathogens. Rev Infect Dis (1983) 1.91
Effect of silica on the innate resistance of inbred mice to Salmonella typhimurium infection. Infect Immun (1979) 1.91
Susceptibility of CBA/N mice to infection with Salmonella typhimurium: influence of the X-linked gene controlling B lymphocyte function. J Immunol (1979) 1.90
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J Infect Dis (1987) 1.90
Species specificity of in vitro Escherichia coli adherence to host intestinal cell membranes and its correlation with in vivo colonization and infectivity. Infect Immun (1980) 1.89
Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis. Lancet (1983) 1.87
Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology (1975) 1.83
Genetic transfer of a mucosal adherence factor (R1) from an enteropathogenic Escherichia coli strain into a Shigella flexneri strain and the phenotypic suppression of this adherence factor. J Infect Dis (1983) 1.78
Phage conversion of Shigella flexneri group antigens. Infect Immun (1975) 1.74
Local and systemic antibody responses to Shigella infection in rhesus monkeys. J Infect Dis (1987) 1.73
Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. Am J Pathol (1986) 1.72
Pathogenesis of Salmonella-mediated intestinal fluid secretion. Activation of adenylate cyclase and inhibition by indomethacin. Gastroenterology (1975) 1.71
Salmonella gastroenteritis in rhesus monkeys. Arch Pathol (1966) 1.70
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. Infect Immun (1990) 1.64
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes. J Infect Dis (1995) 1.64
Laboratory Vibrio cholerae infection in the United States. JAMA (1966) 1.59
Bactericidal antibody assay using 14 C-labeled Neisseria meningitidis. Proc Soc Exp Biol Med (1972) 1.57
Pathophysiology of Salmonella diarrhea in the Rhesus monkey: Intestinal transport, morphological and bacteriological studies. Gastroenterology (1974) 1.56
Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against shigella. J Immunol (1980) 1.56
Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen. Infect Immun (1984) 1.52
Cytotoxicity of Shigella dysenteriae 1 for cultured mammalian cells. Am J Clin Nutr (1980) 1.52
Invasive enteropathic Escherichia coli dysentery. An outbreak in 28 adults. Ann Intern Med (1973) 1.47
Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc Soc Exp Biol Med (1967) 1.46
Quantitation of the adherence of an enteropathogenic Escherichia coli to isolated rabbit intestinal brush borders. Infect Immun (1979) 1.45
Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri, and cholera-mediated rabbit ileal secretion. J Infect Dis (1974) 1.44
The role of Peyer's patches in the local immune response of rabbit ileum to live bacteria. J Immunol (1978) 1.41
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infect Immun (1992) 1.39
Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. J Infect Dis (1972) 1.39
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine (1995) 1.38
Experimental diarrhea: salmonella enterocolitis inthe rat. J Infect Dis (1970) 1.37
Synthesis of aerobactin and a 76,000-dalton iron-regulated outer membrane protein by Escherichia coli K-12-Shigella flexneri hybrids and by enteroinvasive strains of Escherichia coli. Infect Immun (1985) 1.35
Mechanisms and genetics of resistance to sodium lauryl sulfate in strains of Shigella and Escherichia coli. Infect Immun (1971) 1.30
Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile. Infect Immun (1984) 1.28
Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun (1999) 1.23
Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Infect Immun (1996) 1.22
Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri. J Infect Dis (1977) 1.22
Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines. Am J Epidemiol (1972) 1.18
Mechanisms of Shigella pathogenesis. Am J Clin Nutr (1972) 1.17
Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a. Infect Immun (1976) 1.16
Genetics of virulence in Shigella. Microb Pathog (1986) 1.13
Activation of intestinal mucosal adenylate cyclase by Shigella dysenteriae I enterotoxin. Gastroenterology (1976) 1.13
Experimental diarrhea. I. Intestinal water and electrolyte transport in rat salmonella enterocolitis. Gastroenterology (1971) 1.11
Acute enteritis due to Salmonella typhimurium in opium-treated guinea pigs. Arch Pathol (1966) 1.11
Gastric shigellosis in rhesus monkeys. Am J Pathol (1967) 1.10
Recurrent shigellosis complicating human immunodeficiency virus infection: failure of pre-existing antibodies to confer protection. Am J Med (1989) 1.07
Effect of indomethacin on intestinal water transport in salmonella-infected rhesus monkeys. Infect Immun (1977) 1.07
Shigellosis and Escherichia coli diarrhea: relative importance of invasive and toxigenic mechanisms. Am J Clin Nutr (1979) 1.05
Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen. J Biol Chem (1984) 1.05
Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1. Infect Immun (1984) 1.03
Characterization of virulence marker antigen of Shigella spp. and enteroinvasive Escherichia coli. J Clin Microbiol (1989) 1.01
Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells. Infect Immun (1987) 1.00
Secretory immunoglobulin A response following peroral priming and challenge with Shigella flexneri lacking the 140-megadalton virulence plasmid. Infect Immun (1986) 0.99
An O antigen can interfere with the function of the Yersinia pseudotuberculosis invasin protein. Mol Microbiol (1991) 0.99
Effect of guinea pig or monkey colonic mucus on Shigella aggregation and invasion of HeLa cells by Shigella flexneri 1b and 2a. Infect Immun (1986) 0.99
Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis. Med Microbiol Immunol (1981) 0.97
Animal model of human disease. Bacillary dysentery, shigellosis, Shigella dysentery. Animal model: Monkey shigellosis or dysentery. Am J Pathol (1975) 0.96
Invasive Escherichia coli. J Am Vet Med Assoc (1978) 0.96
Immunization with Shigella dysenteriae type 1: evaluation of antitoxic immunity in prevention of experimental disease in rhesus monkeys (Macaca mulatta). J Infect Dis (1977) 0.95
Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen. Vaccine (1992) 0.95